Navigation Links
Researchers devise means to create blood by identifying earliest stem cells
Date:8/29/2008

fetus, when a woman is three or four weeks pregnant. Hemangioblasts can now be derived in unlimited supply experimentally from cultured human embryonic stem cells, which are the origin of all cell types in the body. These hemangioblasts go on to become either blood cells or endothelial cells, which form the inner lining of the heart, veins and arteries, and lymph vessels.

The research grew out of Zambidis' interest in understanding the complex biological processes of blood development and the transformation of embryonic stem cells into the various types of cells that make up the human body.

Hemangioblasts make the body's earliest form of blood in the fetal yolk sac, which nourishes a fertilized egg, and later in the fetal liver and bone marrow. However, because human embryonic cells disappear early in gestation, their role in the early production of blood could not, to the researchers' knowledge, be studied in humans because scientists had no way to identify these human progenitor blood stems cells to follow their development. The scientists suspected they existed in humans, however, because they have been found in mice and zebra fish.

To find the blood stem cell, Zambidis' team grew human embryonic stem cells in culture and fed them growth factors over 20 days. Each time the cell colonies expanded, the researchers sampled individual cells, searching for ones capable of making both endothelial and blood cells, the hallmark of hemangioblasts.

They plucked the newly discovered hemangioblasts from culture dishes, grew them in conditions that Zambidis and his team developed to speed replication, and tested cells for their ability to make endothelial and blood cells. Cells capable of making endothelial cells and all the elements of blood (platelets, and white and red cells) were specifically marked with ACE on their outer surface.

The researchers found not only that ACE was a marker for hemangiob
'/>"/>

Contact: Valerie Mehl
mehlva@jhmi.edu
410-955-1287
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Researchers discover atomic bomb effect results in adult-onset thyroid cancer
2. Antidepressants need new nerve cells to be effective, UT Southwestern researchers find
3. Indiana U researchers launch social networking and research management tool for scientists
4. UC Davis researchers define characteristics, treatment options for XXYY syndrome
5. Munich researchers discover key allergy gene
6. Rapid test for pathogens developed by K-State researchers
7. OU researchers isolate microorganisms that convert hydrocarbons to natural gas
8. UH researchers win top prize for research with humanitarian applications
9. Caltech researchers awarded $10M for molecular programming project
10. Researchers study facial structures, brain abnormalities to reveal formula for detection of autism
11. Mount Sinai researchers discover technology that silences genes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...,, CARLSBAD, Calif., Oct. 23 Ge...ure biosample management for genomic discovery, me...vid Wellis, Ph.D., GenVault,s President and CEO, w...e taking place on October 26th and 27th in La Joll...ill provide an overview of the company together wi...
(Date:11/4/2009)...,, NEW YORK, Oct. 27 Global Rai...mpany and advanced R&D laboratory, today annou...e and is prepared to actively commercialize its su...dge biometric security offerings. ,, During the...llions of dollars to develop and deploy a series o...
(Date:11/4/2009)...,, CARLSBAD, Calif., Nov. 4 Gen...hat William Brody, M.D., Ph.D., has joined its Boa...idential Chair of the Salk Institute, is an acclai...ior to joining the Salk Institute, Dr. Brody serve...e is a member of the National Academy of Engineeri...
Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Brain Fitness Makes Boomers Age Younger 4605 1Brain Fitness Makes Boomers Age Younger 4605 2BioArts International Clones 9 11 Hero Dog Owner to Receive Five Cloned Puppies June 17 in Los Angeles 49158 1BioArts International Clones 9 11 Hero Dog Owner to Receive Five Cloned Puppies June 17 in Los Angeles 49158 2BioArts International Clones 9 11 Hero Dog Owner to Receive Five Cloned Puppies June 17 in Los Angeles 49158 3European Airports Actively Engaging on Reducing CO2 Despite the Crisis 12664 1European Airports Actively Engaging on Reducing CO2 Despite the Crisis 12664 2European Airports Actively Engaging on Reducing CO2 Despite the Crisis 12664 3
...n damage DNA, reducing its ability to replicate an...he development of skin cancers. However, not much ...s altered upon exposure to UV light. Now a group o...method to measure changes in the mechanical proper...r Marszalek and his colleagues have conducted sing...
...MS) tends to go into remission while women are pre...ing neurodegenerative disease, according to Univer...pregnancy-related hormone is responsible for rebui... In a paper to be published in the February 21 iss...rchers from the U of C,s Faculty of Medicine repor...
...ther, more widely used subjects of scientific stud... or mouse. But University of Illinois cell and dev...s it should be. As it turns out, the tiny, seeming... study of germ cells, precursors of eggs and sperm...arian Newmark studies, Schmidtea mediterranea, is ...
Other Biology News:Stretching DNA to the limit 2Pregnancy hormone key to repairing nerve cell damage 2Pregnancy hormone key to repairing nerve cell damage 3Study of planarians offers insight into germ cell development 2
(Date:11/6/2009)...RY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Bio...the "Company") today announced updated results fro...atients with sarcomas metastatic to the lung in a ...Tissue Oncology Society Meeting held in Miami Beac...resentation, entitled "A Phase II Study of Intrave...
(Date:11/5/2009)...ERSBURG, Md., Nov. 5 Gen...ancial results for the third quarter ended Septemb...llion ($0.04 per share) for the three months ended... million ($0.08 per share) in the comparable quart..., 2009, GenVec,s net loss was $14.1 million ($0.15...
(Date:11/5/2009)...O CORDOVA, Calif., Nov. 5 /PRNewswire-FirstCall/ -...supplier of innovative products for processing and...for the first quarter of fiscal 2010. ,, For th...ported revenues of $5.2 million, a 15 percent incr...arter a year ago. The Company said the key contrib...
(Date:11/5/2009)...VALE, Calif., Nov. 5 Cep...cutives will be speaking at the following investor... via webcast. , , Credit Suisse He...Thursday, 12 November, 2009 at 10 a.m. Mountain Ti...ram, London, England, Tuesday, 1 D...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2
...EAST NORRITON, Pa., Feb. 27 Tengion Inc., a clini... the development of,neo-organs and neo-vessels, an...o its Board of Directors. Mr. Randall brings more ...ive, CFO and CEO at public and private,companies t...device,manufacturing and electronics industries., ...
...SOUTH SAN FRANCISCO, Calif., Feb. 27 Anesiva,Inc....aughlin, the company,s,chief executive officer, wi...ificant Investment Options in Healthcare Conferenc...., To access the live webcast or the subsequent a...om, go to the Investors page, and click on Events...
...RIO DE JANEIRO, Brazil, Feb. 26 One of,Brazil,s l...ofarma,Distribuidora de Produtos Farmaceuticos S.A...as just announced its results for the fourth quart...S FOR THE PERIOD, -- Profarma,s market share brea...ntage points above the share reached in the 3Q07 a...
Other Biology Technology:Tengion Appoints Jeff Randall to Board of Directors 2
Mycoplasma Testing from AbD Serotec
...Exonuclease-free Klenow Fragment is a genetically ...xonuclease activity has been removed, leaving only...f exonuclease activity makes Exo- Klenow Fragment ...ng of DNA probes by the random primed method, and ...
T4 RNA Ligase from Roche Applied Science
T7 RNA Polymerase from Roche Applied Science
Biology Products: